OTCMKTS:SONVY - Sonova Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 7 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$49.44
▲ +1.67 (3.50%)
1 month | 3 months | 12 months
Get New Sonova Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SONVY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SONVY

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Sonova in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $49.44.
Hold
The current consensus among 8 contributing investment analysts is to hold stock in Sonova.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/8/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/6/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
12/5/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
3/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 1 sell ratings
6/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 6 hold ratings
  • 1 sell ratings
8/31/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 1 sell ratings
10/30/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 0 sell ratings
11/29/2020

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
11/24/2020JPMorgan Chase & Co.Reiterated RatingNeutral
i
11/23/2020Berenberg BankReiterated RatingHold
i
11/17/2020Credit Suisse GroupReiterated RatingOutperform
i
11/17/2020UBS GroupReiterated RatingNeutral
i
11/5/2020Berenberg BankReiterated RatingHold
i
10/8/2020Credit Suisse GroupReiterated RatingOutperform
i
10/8/2020CitigroupInitiated CoverageNeutral
i
9/30/2020JPMorgan Chase & Co.Reiterated RatingNeutral
i
9/29/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
i
9/29/2020UBS GroupReiterated RatingNeutral
i
9/2/2020UBS GroupReiterated RatingNeutral
i
7/27/2020Morgan StanleyUpgradeUnderweight ➝ Equal Weight
i
5/22/2020UBS GroupDowngradeBuy ➝ Neutral
i
5/21/2020JPMorgan Chase & Co.UpgradeNeutral
i
5/20/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
i
5/12/2020Berenberg BankReiterated RatingHold
i
4/17/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
i
4/9/2020Jefferies Financial GroupDowngradeBuy ➝ Hold
i
1/5/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
i
10/31/2019The Goldman Sachs GroupDowngradeNeutral ➝ Sell
i
9/10/2019Jefferies Financial GroupUpgradeHold ➝ Buy
i
1/14/2019UBS GroupUpgradeNeutral ➝ Buy
i
2/6/2017UBS GroupDowngradeNeutral ➝ Sell
i
9/29/2016Credit Suisse GroupReiterated RatingOutperform
i
12/8/2015Morgan StanleyDowngradeEqual Weight ➝ Underweight
i
(Data available from 11/29/2015 forward)
Sonova logo
Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. It operates through two segments, Hearing Instruments and Cochlear Implants segments. It offers wireless communication products, rechargeable hearing aids, and professional audiological care services. The company provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand; and professional hearing care services under the AudioNova, Audium, AuditionSanté, Boots Hearingcare, Connect Hearing, Fiebing, Geers, Hansaton, Lapperre, Lindacher, Schoonenberg, Triton, and Vitakustik brands. Sonova Holding AG sells its products through wholesale companies and independent distributors; and provides professional audiological care services through a network of approximately 3,500 stores and clinics. It operates in the Americas, Europe, the Middle East, Africa, and the Asia/Pacific. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.
Read More

Today's Range

Now: $49.44
$49.09
$49.84

50 Day Range

MA: $51.05
$47.20
$54.50

52 Week Range

Now: $49.44
$29.41
$54.77

Volume

12,433 shs

Average Volume

23,227 shs

Market Capitalization

$15.92 billion

P/E Ratio

33.18

Dividend Yield

N/A

Beta

0.71